Contribution · Application — Research

AI for Clinical Protocol Generation

A clinical protocol is a 100-page document covering science, design, stats, safety, and regulatory compliance. LLMs grounded in therapeutic templates, prior studies, and regulator guidance can draft solid first versions — clinician-scientists, biostatisticians, and regulatory affairs refine and sign. The efficiency is real; patient-safety stakes mean every detail is reviewed, and AI never signs alone.

Application facts

Domain
Research
Subdomain
Clinical research
Example stack
Claude Opus 4.7 for long-form protocol drafting · LlamaIndex over prior protocols + regulator guidance · Template library (SPIRIT 2013 compliance) · pgvector for similarity to prior trials · Regulatory review workflow with change tracking

Data & infrastructure needs

  • Prior protocol library and trial outcomes
  • Regulator guidance (CDSCO, FDA, EMA, ICMR)
  • Therapeutic area literature
  • Statistical analysis plan templates

Risks & considerations

  • Unsafe protocol elements slipping through
  • Regulatory non-compliance — ICH-GCP, CDSCO, ICMR guidelines
  • IP — competitor sensitivity on novel trial designs
  • Hallucinated prior studies or endpoint definitions
  • Over-standardization reducing scientific creativity

Frequently asked questions

Is AI protocol generation safe?

Only with rigorous human review at every step: clinician-scientists on scientific merit, biostatisticians on analysis plan, regulatory affairs on compliance, ethics committee on participant safety. The LLM drafts; humans sign and are accountable.

What LLM is best?

Claude Opus 4.7 handles long regulatory prose well. Pair with deterministic tools: SPIRIT compliance checker, statistical plan validators. Never let the LLM be the sole author of any safety-critical section.

Regulatory concerns?

India: CDSCO, ICMR, ICH-GCP, New Drugs and Clinical Trials Rules 2019. US: FDA, IRB, ICH-GCP. EU: EMA, Clinical Trials Regulation, country ECs. WHO GCP underpins all.

Sources

  1. ICH-GCP E6(R3) — accessed 2026-04-20
  2. CDSCO — accessed 2026-04-20
  3. SPIRIT 2013 — accessed 2026-04-20